Saphris Approved for Schizophrenia and Bipolar Disorder
Two severe psychiatric illnesses The drug Saphris (asenapine) has been approved by the U.S. Food and Drug Administration to treat adults with either schizophrenia or bipolar I disorder, the agency said Friday....
More -->
More articles below:
U.S. Spending on Mental Health Care Soaring
FDA Panel OKs Newer Antipsychotics for Children
Risperdal Consta Approved for Bipolar Disorder
Kids' Risks Increase When Parents Are Bipolar
Common Genes Link Bipolar Disorder, Schizophrenia
DON'T HAVE Rx COVERAGE?Click Here to print out your FREE OPTIMIZERx Card and instantly begin savings on your next prescriptions!
Bipolar Disorder coupon
search results...
|
| eHealthInsurance - FREE Instant Quotes!
|
| Lamictal - Stay on Track program |
|
Overview:
Join the Stay on Track program. It’s designed to help you continue to take LAMICTAL as prescribed for the maintenance treatment of bipolar disorder. |
*Program offers and eligibility are independent of OPTIMIZERx, subject to change by the manufacturer and may require leaving the site to directly enroll into the manufacturer's program. Please review terms & conditions carefully.
